Development and Research into Functional Foods from Hydrolyzed Whey Protein Powder with Sialic Acid as Its Index Component - III. Bacterial Reverse Mutation Testing of Hydrolyzed Whey Protein Powder Containing Normal Concentration of Sialic Acid (7%) with Enzyme Separation Method -

Sialic Acid를 지표성분으로 하는 유청가수분해단백분말의 기능성식품 개발연구 - III. 효소분리로 7% Siailc Acid가 표준적으로 함유된 유청가수분해단백분말의 미생물복귀돌연변이시험 연구 -

  • Received : 2016.06.01
  • Accepted : 2016.06.24
  • Published : 2016.06.30

Abstract

The ultimate research goal of the current study was a development of hydrolyzed whey protein powder (7%-GNANA) manufactured with normal content of sialic acid, a marker compound, that is naturally occurring at 7% concentration in GMP obtained from the milk protein. GMP is a safe food, used worldwide in infant and baby foods, etc. The test substance was prepared using (7% sialic acid containing) GMP as a raw material, and then using alcalase, an enzyme approved as a food additive, after separation of sialic acid with 100% efficiency and 7%-GNANA (containing 7% sialic acid and protein; product name: HELICOBACTROL-7) provided by MEDINUTROL Inc. (Korea). Bacterial reverse mutation (Ames) test was conducted in accordance with GLP Guideline using the test substance specified above. To identify its mutagenic potential against microorganisms, histidine auxotrophic strains of Salmonella Typhimurium, TA98, TA100, TA1535, and TA1537, and tryptophan auxotrophic strain of Escherichia coli, WP2uvrA, were used. The bacterial reverse mutation (Ames) test was performed by dividing the test substances into five different concentration groups (0, 61.7, 185, 556, 1,670, $5,000{\mu}g/plate$). Results of this experiment did not reveal repetitive increase of colony generating values or positive criteria for reverse mutagenicity for any concentration of test substances in any of the five strains, regardless of the presence of a metabolic activation system, and no dose-dependency was identified. In conclusion, the safety of 7%-GNANA test substance was verified by bacterial reverse mutation test conducted before registration of 7%-GNANA as a food additive.

본 시험은 GMP 내 기본적으로 7%로 결합되어 있는 sialic acid의 함유량을 그대로 보유하도록 제조한 유청단백가수분말(시험물질명: 7%-GNANA)을 기능성 식품 원료 개발함에 최종 연구목표를 두었다. 시험물질은 GMP(7% sialic acid 함유)를 원료로 하고, 여기에 식품첨가물로 허용된 효소인 Alcalase를 사용하여 지표성분인 sialic acid를 100% 효율로 분리시킨 후, 동결 건조한 7%-GNANA(7% sialic acid와 GMP 단백질로 구성, 제품명: HELICOBACTROL-7)을 (주)한일바이오메드사(한국)에서 공여 받아 GLP 가이드라인에 따라 미생물복귀돌연변이시험을 실시하였다. 미생물에 대한 돌연변이 유발성 유무를 검색하기 위해 히스티딘 요구성 균주인 Sal. typhimurium TA98, TA100, TA1535 및 TA1537과 트립토판 요구성 균주인 E. coli WP2uvrA를 이용하였다. 미생물복귀돌연변이시험은 시험물질을 5단계의 농도군(0, 61.7, 185, 556, 1,670, $5,000{\mu}g/plate$)으로 하여 평가하였다. 본 시험을 통한 평가결과, 대사활성계 존재 유무와 관계없이 모든 균주에서 시험물질의 각 농도에 의한 복귀돌연변이 유발원 양성기준인 콜로니 생성수치가 재현성 있는 증가를 나타내지 않았으며, 용량의존성도 확인되지 않았다. 결론적으로, 시험물질인 7% G-NANA의 식품첨가물로서 등록을 위하여 수행한 미생물돌연변이시험에서 안전성이 확인되었다.

Keywords

References

  1. Aimutis, W. R. 2004. Bioactive properties of milk proteins with particular focus on anticariogenesis. J. Nutr. 134:989-995. https://doi.org/10.1093/jn/134.4.989S
  2. Brody, E. P. 2000. Biological activities of bovine glyco-macropeptide. British Journal of Nutrition 84:S39-S46.
  3. Gorog, P. and Kovacs, I. B. 1978. Anti-inflammatory effect of sialic acid. Agents and Actions 8:543-545. https://doi.org/10.1007/BF02111443
  4. Iijima, R., Takahashi, H., Namme, R., Ikegami, S. and Yamazaki, M. (2004). Novel biological funtion of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Letters 561:163-166. https://doi.org/10.1016/S0014-5793(04)00164-4
  5. Kelleher, S. L., Chatterton, D., Nielsen, K. and Lonnerdal, B. 2003. Glycomacropeptide and ${\alpha}$-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am. J. Clin. Nutr. 77:1261-1268. https://doi.org/10.1093/ajcn/77.5.1261
  6. Korea Food and Drug Administration(KFDA). 2014. The above study was conducted in accordance with the Ministry of Food and Drug Safety. KFDA Notice No. 2014-136 (Jul. 30.).
  7. Korea Food and Drug Administration(KFDA). 2015. Guidelines for toxicity tests in drugs, etc. KFDA Notice No. 2014-67 (Feb. 12).
  8. Maron, D. M. and Ames, B. N. 1983. Revised methods for the Salmonella mutagenicity test. Mutation Res. 113:173-215. https://doi.org/10.1016/0165-1161(83)90010-9
  9. Marshall, S. C. 1991. Casein macropeptide from whey. A new product opportunity. Food Res. Quar. 15:86-91.
  10. Moon, Y.-I., Lee, W. and Oh, S. 2005. Glycomacropeptide hydrolysed from bovine ${\kappa}$-casein: II. Chromatographic changes of ${\kappa}$-casein macropeptide as related to trichloroacetic acid concentration. Korean J. Food Sci. Ani. Resour. 25: 478-482.
  11. Organization for Economic Cooperation and Development. 1993. OECD guideline for the testing of chemicals, 'Guidelines for the management of non-clinical studies' OECD Test guidelines (No. 473) and GLP Center Standard Operating Procedures.
  12. Organization for Economic Cooperation and Development. 2008. OECD Guidelines 408 for the testing of chemicals: Repeated Dose 90-day Oral Toxicity Study in Rodents.
  13. Springer-Verlag, R. S. 1984. Sialic acids: Chemistry, metabolism and function. Carbohydrate Research 129:c5-c7. https://doi.org/10.1016/0008-6215(84)85324-0
  14. Takahashi, N., Asakawa, S., Shunichi, D. and Tadashi, I. 1992. Hypoallergenic nutritive composition. Freench Pat. Appl. Fr. 2667 850A1.
  15. Wang, B. 2009. Sialic acid is and essential nutrient for brain development and cognition. Annu. Rev. Nutr. 29: 177-222. https://doi.org/10.1146/annurev.nutr.28.061807.155515
  16. Wang, B. and Brand-Miller, J. 2003. The role and potential of silaic acid in human nutrition. European Journal of Clinical Nutrition 57:1351-1369. https://doi.org/10.1038/sj.ejcn.1601704
  17. Wang, B., Brand-Miller, J., McVeagh, P. and Petocz, P. 2001. Concentration and distribution of sialic acid in human milk and infant $formulas^{1-3}$. Am. J. Clin. Nutr. 74:510-515. https://doi.org/10.1093/ajcn/74.4.510
  18. Wang, B., Yu, B., Karim, M., Hu, H., Sun, Y., McGreevy, P., Petocz, P., Held, S. and Brand-Miller, J. 2007. Dietary sialic acid supplementation improves learning and memory in $piglets^{1-3}$. Am. J. Clin. Nutr. 85:561-569. https://doi.org/10.1093/ajcn/85.2.561
  19. Yoon, Y. C., Cho, J. K., Song, C. H., Lee, S. and Chung, C. I. 2000. Purification of the glycomacropeptide from cheese whey. Korean J. Food Sci. Ani. Resour. 20:159-165.